Cystic fibrosis | Guidance and guideline topic | NICE

Everything NICE has produced on the topic of cystic fibrosis. Includes related advice.

2 new

and

0 updated

products since January 2017.

Technology appraisal guidance

Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis (TA276) March 2013
Lumacaftor–ivacaftor for treating cystic fibrosis homozygous for the F508del mutation (TA398) July 2016
Mannitol dry powder for inhalation for treating cystic fibrosis (TA266) November 2012

NICE Evidence summaries

Cystic fibrosis: long-term azithromycin (ESUOM37) November 2014

In development

Cystic fibrosis (GID-QS10052) May 2018 Quality standards
Cystic fibrosis: diagnosis and management (GID-CGWAVE0736) October 2017 NICE guidelines